Skip Navigation

Cardiovascular Research 2006 69(1):263-271; doi:10.1016/j.cardiores.2005.08.013
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Hinagata, J.-i.
Right arrow Articles by Sawamura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hinagata, J.-i.
Right arrow Articles by Sawamura, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2005, European Society of Cardiology

Oxidized LDL receptor LOX-1 is involved in neointimal hyperplasia after balloon arterial injury in a rat model

Jun-ichi Hinagataa,b, Makoto Kakutania, Takao Fujiic, Takahiko Narukod, Nobutaka Inouea, Yoshiko Fujitaa, Jawahar L. Mehtae, Makiko Uedac and Tatsuya Sawamuraa,b,*

aDepartment of Vascular Physiology, National Cardiovascular Center Research Institute, Suita, Osaka 565-8565, Japan
bDepartment of Molecular Pathophysiology, Graduate School of Pharmaceutical Sciences, Osaka University, Suita, Osaka 565-0871, Japan
cDepartment of Pathology, Osaka City University Medical School, Osaka 545-8585, Japan
dDepartment of Cardiology, Osaka City General Hospital, Osaka 534-0021, Japan
eDivision of Cardiovascular Medicine, University of Arkansas Medical School, Little Rock, AR, United States

*Corresponding author. Department of Vascular Physiology, National Cardiovascular Center research Institute, 5-7-1, Fujishirodai, Suita, Osaka, 565-8565, Japan. Tel.: +81 6 6833 5012x2518; fax: +81 6 6835 5329. Email address: t-sawamura{at}umin.ac.jp

Objective: LOX-1 is a multi-ligand receptor originally identified as the endothelial oxidized LDL receptor. LOX-1 expression is also induced in smooth muscle cells in response to proinflammatory and oxidative stimuli. Here, we report on the role of LOX-1 in intimal hyperplasia, in which proinflammatory and oxidative stimuli are increased.

Methods and results: Left common carotid artery of rat was injured by a balloon catheter. The expression of LOX-1 was significantly increased within 24 h after the balloon injury and peaked at day 7. LOX-1 expression was observed predominantly in medial smooth muscle cells until day 3, and then shifted to predominantly intimal smooth muscle cells. At day 14, the expression was concentrated in the regenerated endothelial cells. To examine the contributory role of LOX-1 in the growth of intimal smooth muscle cells, rats were administered anti-LOX1 antibody intravenously every 3 days after balloon injury. Anti-LOX-1 antibody administration effectively suppressed intimal hyperplasia, oxidative stress, and leukocyte infiltration compared with control IgG. These findings suggest the importance of LOX-1 expression in the pathogenesis of neointimal formation in conjunction with oxidative stress and leukocyte infiltration.

Conclusion: The LOX-1 expressed in smooth muscle cells is involved in intimal hyperplasia in a rat model of balloon injury. Manipulation of LOX-1 activity is a novel potential therapeutic target to prevent restenosis after angioplasty.

KEYWORDS Restenosis; Neointimal formation; LOX-1; Smooth muscle cells


Time for primary review 31 days


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
E.-H. Yao, N. Fukuda, T. Ueno, H. Matsuda, H. Nagase, Y. Matsumoto, H. Sugiyama, and K. Matsumoto
A pyrrole-imidazole polyamide targeting transforming growth factor-{beta}1 inhibits restenosis and preserves endothelialization in the injured artery
Cardiovasc Res, March 1, 2009; 81(4): 797 - 804.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
Y. Fujita, A. Kakino, N. Nishimichi, S. Yamaguchi, Y. Sato, S. Machida, L. Cominacini, Y. Delneste, H. Matsuda, and T. Sawamura
Oxidized LDL Receptor LOX-1 Binds to C-Reactive Protein and Mediates Its Vascular Effects
Clin. Chem., February 1, 2009; 55(2): 285 - 294.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E.-H. Yao, N. Fukuda, T. Ueno, H. Matsuda, K. Matsumoto, H. Nagase, Y. Matsumoto, A. Takasaka, K. Serie, H. Sugiyama, et al.
Novel Gene Silencer Pyrrole-Imidazole Polyamide Targeting Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Attenuates Restenosis of the Artery After Injury
Hypertension, July 1, 2008; 52(1): 86 - 92.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
V. Mollace, S. Ragusa, I. Sacco, C. Muscoli, F. Sculco, V. Visalli, E. Palma, S. Muscoli, L. Mondello, P. Dugo, et al.
The Protective Effect of Bergamot Oil Extract on Lecitine-like OxyLDL Receptor-1 Expression in Balloon Injury-related Neointima Formation
Journal of Cardiovascular Pharmacology and Therapeutics, June 1, 2008; 13(2): 120 - 129.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.